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Key points
 The strength, functional significance and origins of parasympathetic innervation of the left
ventricle remain controversial.
 This study tested the hypothesis that parasympathetic control of left ventricular contractility
is provided by vagal preganglionic neurones of the dorsal motor nucleus (DVMN).
 Under β-adrenoceptor blockade combined with spinal cord (C1) transection (to remove
sympathetic influences), systemic administration of atropine increased left ventricular contra-
ctility in rats anaesthetized with urethane, confirming the existence of a tonic inhibitory
muscarinic influence on cardiac inotropy.
 Increased left ventricular contractility in anaesthetized rats was observed when DVMN neuro-
nes were silenced.
 Functional neuroanatomical mapping revealed that vagal preganglionic neurones that have an
impact on left ventricular contractility are located in the caudal region of the left DVMN.
 These neurones provide functionally significant parasympathetic control of left ventricular
inotropy.
Abstract The strength, functional significance and origins of direct parasympathetic innervation
of the left ventricle (LV) remain controversial. In the present study we used an anaesthetized rat
model to first confirm the presence of tonic inhibitory vagal influence on LV inotropy. Using
genetic neuronal targeting and functional neuroanatomicalmappingwe tested the hypothesis that
parasympathetic control of LV contractility is provided by vagal preganglionic neurones located
in the dorsal motor nucleus (DVMN). It was found that under systemic β-adrenoceptor blockade
(atenolol) combined with spinal cord (C1) transection (to remove sympathetic influences),
intravenous administration of atropine increases LV contractility in rats anaesthetized with
urethane, but not in animals anaesthetized with pentobarbital. Increased LV contractility in
rats anaesthetized with urethane was also observed when DVMN neurones targeted bilaterally
to express an inhibitory Drosophila allatostatin receptor were silenced by application of an insect
peptide allatostatin. Microinjections of glutamate and muscimol to activate or inhibit neuronal
cell bodies in distinct locations along the rostro-caudal extent of the left and rightDVMNrevealed
that vagal preganglionic neurones, which have an impact on LV contractility, are located in the
caudal region of the left DVMN. Changes in LV contractility were only observed when this sub-
population of DVMN neurones was activated or inhibited. These data confirm the existence of a
tonic inhibitory muscarinic influence on LV contractility. Activity of a subpopulation of DVMN
neurones provides functionally significant parasympathetic control of LV contractile function.
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Introduction
The heart is controlled by the parasympathetic and
sympathetic limbs of the autonomic nervous system.
Sympathetic nerves innervate the sinoatrial and atrio-
ventricular nodes, the atria, ventricles and the conducting
tissue. Parasympathetic efferent fibres are known to
control nodal tissues and atria. The role of the
vagal innervation of the ventricles, however, remains
controversial (Coote, 2013). The majority of physio-
logy textbooks state that the vagal innervation of the
ventricle is sparse and direct parasympathetic control
of ventricular contractility is insignificant. This view
persists in both the scientific and the educational
literature despite evidence obtained in various species
(from mouse to human) demonstrating the presence
of choline acetyltransferase-positive nerve fibres, acetyl-
cholinesterase andmuscarinic receptors in both ventricles
(for a recent review see Coote, 2013). Rich cholinergic
innervation of epicardial and endocardial ventricular
surfaces was demonstrated in human (Kent et al. 1974;
Pauza et al. 2000), pig (Crick et al. 1999; Ulphani et al.
2010) and rat (Mastitskaya et al. 2012) hearts.
Although the functional significance of direct
parasympathetic influence on ventricular contractility at
resting conditions remains unknown, data obtained in
dogs, pigs and humans have demonstrated that electrical
stimulation of the vagus nerve decreases the force of
ventricular contraction independent of heart rate changes
(Eliakim et al. 1961; Degeest et al. 1965c; Lewis et al.
2001). These data are also supported by the results of in
vitro studies conducted on isolated rat (McMorn et al.
1993), cat (Hommers et al. 2003), guinea-pig (Zang
et al. 2005) and ferret (Ito et al. 1995; Dobrzynski et al.
2002) cardiomyocytes. For example, ferret ventricular
cardiomyocytes respond to a prototypical effector
molecule of the parasympathetic nervous system –
acetylcholine (ACh) – with a reduction in twitch
magnitude (Dobrzynski et al. 2002). These effects of
ACh are mediated via rapid phosphorylation of certain
inwardly rectifying potassium channels (in particular
Kir3.1 and Kir3.4, expressed throughout the heart
including the ventricles) (Dobrzynski et al. 2001),
potentiation of K+ currents and/or reduction of Ca2+
currents (Dobrzynski et al. 2002).
Neuronal tracing studies conducted in rats (Nosaka et al.
1979, 1982; Stuesse, 1982; Izzo et al. 1993;Cheng&Powley,
2000; Sampaio et al. 2014), cats (Sugimoto et al. 1979;
Ciriello & Calaresu, 1980; Geis & Wurster, 1980; Kalia &
Mesulam, 1980; Bennett et al. 1981; Geis et al. 1981;Miura
&Okada, 1981; Ciriello & Calaresu, 1982; Ford et al. 1990;
Jones et al. 1995), dogs (Bennett et al. 1981; Hopkins &
Armour, 1982, 1984; Plecha et al. 1988) and pigs (Hopkins
et al. 1984, 1997) identified cardiac vagal preganglionic
neurones within the brainstem nucleus ambiguus and
the dorsal vagal motor nucleus (DVMN). Neurones of
the nucleus ambiguus have rhythmic, respiratory-related
patterns of discharge with B fibre axons innervating
nodal tissue and their rhythmic activity underlies the
respiratory sinus arrhythmia (McAllen & Spyer, 1976;
McAllen & Spyer, 1978a,b; Ciriello & Calaresu, 1982).
The relative proportion of DVMN neurones projecting
to the heart is believed to be low (Jones, 2001) and
their functional significance in the control of cardiac
function remains unknown. DVMNneurones have slowly
conducting C fibre (non-myelinated) axons (Ciriello &
Calaresu, 1980; Nosaka et al. 1982; Jones et al. 1995, 1998)
and their activity is not respiratory modulated. There is
evidence that these neurones protect (via a muscarinic
mechanism) ventricular cardiomyocytes against acute
ischaemia/reperfusion injury (Mastitskaya et al. 2012) and
control ventricular excitability (Machhada et al. 2015),
suggesting that the DVMN contains vagal preganglionic
neurones that innervate the left ventricle (LV).
In the present study we used an anaesthetized rat model
to test the hypothesis that DVMN vagal preganglionic
neurones contribute to the control of left ventricular
contractility. Firstwe confirmed thepresence of tonic vagal
influenceon left ventricular inotropy (revealedby systemic
muscarinic receptor blockade). Next we determined the
effect of selective silencing of DVMN neurones on
left ventricular contractility and finally identified the
anatomical location of the functional subpopulation of the
DVMNneurones that are responsible for parasympathetic
control of the LV.
Methods
All the experimentswereperformed inaccordancewith the
European Commission Directive 2010/63/EU (European
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Convention for the Protection of Vertebrate Animals used
for Experimental and Other Scientific Purposes) and the
UK Home Office (Scientific Procedures) Act (1986) with
project approval from the Institutional Animal Care and
Use Committee.
Animal preparation
Adult male Sprague-Dawley rats (380–450 g; Charles
River, Oxford, UK) were anaesthetized with urethane
(1.3 g kg−1 I.P.; following 4% isoflurane induction)
or pentobarbitone sodium (induction 60 mg kg−1 I.P.;
maintenance 10–15 mg kg−1 h−1 I.V.). As anaesthesia is
known to have a significant impact on vagal activity,
experiments designed to reveal tonic parasympathetic
influence on the LV (Experiments 1–3) were conducted
in animals anaesthetized with urethane which has been
shown to preserve the level of chronotropic vagal tone
similar to that in decerebrate animals (O’Leary & Jones,
2003). Experiments designed to recruit vagal activity
(Experiment 3) were conducted in rats anaesthetized with
pentobarbital which reduces vagal tone (O’Leary & Jones,
2003).
Adequate anaesthesia was ensured throughout the
experiment through continuous monitoring of heart
rate and arterial blood pressure (ABP) stability and the
absence of a withdrawal response to a paw pinch. With
an animal in a supine position, the femoral artery and
both femoral veins were cannulated for measurement
of systemic ABP, fluid infusion and administration of
drugs. A 2F Millar pressure catheter (SPR-320NR, Millar
Instruments, Houston, TX, USA) was advanced via the
right carotid artery and positioned within the chamber of
the LV to monitor changes in LV pressure (LVP) (Fig. 1A).
The trachea was cannulated and the animal was ventilated
with room air using a small rodent ventilator (Model 683,
Harvard Apparatus, Holliston, MA, USA) with a tidal
volume of 8–10 ml kg−1 set at a normal respiratory
frequency of 60 strokes min−1. Body temperature
was maintained with a servo-controlled heating pad at
37.0 ± 0.5°C. Partial pressures of O2 and CO2 as well as
pHof the arterial bloodweremeasured every hour (348EX
RAPIDLabbloodgas analyser, Siemens, London,UK).The
rate and volume of mechanical ventilation were adjusted
and oxygen was added to the respiratory gas mixture (if
required) tomaintain blood gases within the physiological
ranges. ABP, LVP, tracheal pressure and standard lead II
ECGwere recordedusing aPower1401 interface andSpike2
software (Cambridge Electronic Design, Cambridge, UK).
Average waveforms were used to determine systolic blood
pressure, diastolic blood pressure, mean arterial blood
pressure (MAP), LV end systolic pressure (LVESP) and
LV end diastolic pressure (LVEDP). The differential of LV
pressure (LVdP/dt) was derived from the LVP recording
using the slope function.
Assessment of left ventricular contractility
The atria were paced at a rate of 10 or 20% above the
resting heart rate using silver wire electrodes advanced
via the oesophagus to the level of the heart (Fig. 1A).
To remove sympathetic influences, the β-adrenoceptor
blocker atenolol was administered (initial bolus dose
2mg kg−1 I.V., followed by 3mg kg−1 h−1 I.V. infusion) and
the spinal cord was transected at the cervical level (C1).
To restore arterial blood pressure (MAP 100 mmHg)
after C1 transection, vasopressin (0.15 nM in saline)
was infused intravenously at a rate of 10 μl min−1
(Fig. 1B). The maximum of the first differential of
LVP (LVdP/dtmax, mmHg s−1) measures the inotropic
state but with a caveat of load dependency. Systemic
β-adrenoceptor blockade, C1 transection and vasopressin
infusion remove sympathetic influences, provide constant
loading conditions and fixed filling times (whilst pacing),
allowing the use of LVdP/dtmax as a measure of LV contra-
ctility (further assessment of the LV contractile function
by indexing of the maximum of the first differential to
instantaneous LVP [(LVdP/dtmax)/LVP] or deriving the
maximum instantaneous ratio of this [(LVdP/dt)/LVP]max
was not used due to known limitations (Van den Bos
et al. 1973)).
Ultrasound imaging of the left ventricle
LV pressure–area loop analysis was performed by
combinedmeasurement of LVP using a 2FMillar pressure
catheter and LV imaging using a Vevo 2100 ultrasound
system (VisualSonics, Amsterdam, the Nertherlands). A
24 MHz microscan transducer was used to provide a
parasternal long-axis view (Fig. 1C). Precautions were
taken to minimize the effect of cardiac preload using the
approach previously described (Lewis et al. 2001). With
a suture positioned sub-diaphragmatically around the
inferior vena cava as a snare to lower systolic bloodpressure
by25mmHg while pacing at a rate of 10% above resting
heart rate, LVP–area data were acquired in segments each
comprising 15 heart beats (Fig. 1D). Measurements were
made before and after systemic β-adrenoceptor blockade
with atenolol (3mg kg−1 I.V.) and again following systemic
muscarinic receptor blockadewith atropinemethyl nitrate
(2 mg kg−1; I.V.). Using LV cross-sectional area (mm2) as
a surrogate measure of LV volume, the regression slope
of the end-systolic LVP–area relationship was used to
determine the end-systolic elastance (Ees, mmHg mm−2;
Fig. 1D) – an index of LV inotropic state which is largely
insensitive to loading conditions.
Genetic targeting of the DVMN vagal pre-ganglionic
neurones
Vagal preganglionic neurones of the DVMN characteri-
stically express the transcriptional factor Phox2 and
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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can be targeted to express the gene of interest using
viral vectors with Phox2-activated promoter PRSx8
(Lonergan et al. 2005). DVMN neurones along the whole
rostro-caudal extent of the left and right nuclei were trans-
duced with lentiviral vectors (LVVs) to express either
the Gi-protein-coupled Drosophila allatostatin receptor
(AlstR) or enhanced green fluorescent protein (eGFP,
control). The plasmid pTYF-PRSx8-AlstR-IRES2-eGFP
was cloned into the LVV. LVV titres were between 1×109
and 1×1010 transducing units ml−1. Viral concentration
and titration were carried out as described by Coleman
et al. (2003). Validation of the transgene specificity in
targetingDVMNneurones to express AlstR and efficacy of
the natural ligand of AlstR, the insect peptide allatostatin,
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Figure 1. Experimental approaches used for the assessment of left ventricular (LV) contractility in
anaesthetized rats
A, representative recordings obtained in a pentobarbital-anaesthetized rat illustrating simultaneous monitoring of
heart rate (HR), arterial blood pressure (ABP), left ventricular pressure (LVP), derived mean arterial blood pressure
(MAP) and the first differential of left ventricular pressure (LVdP/dt). Inset, schematic drawing illustrating placement
of a 2F Millar pressure catheter in the LV chamber (advanced via the right common carotid artery) and positioning
of atrial pacing electrodes in the lumen of the oesophagus at the level of the atria. B, representative example of
simultaneous monitoring of HR, MAP, ABP, maximum of the first differential of the LV pressure (LVdP/dtmax) and LV
end-systolic pressure (LVESP) in conditions of systemic β-adrenoceptor blockade and spinal cord transection at C1
level before and during intravenous infusion of vasopressin (0.15 nM, 10 μl min−1) to restore MAP to100 mmHg.
Normal arterial pH, PCO2 and PO2 weremaintained by adjusting parameters of mechanical ventilation and providing
supplemental oxygen in the inspired gas mixture. Sympathetic blockade and vasopressin infusion provide constant
loading conditions and fixed filling times whilst pacing, allowing the use of LVdP/dtmax as a measure of LV
contractility. C, a B-mode ultrasound image of a parasternal long axis view of the LV with a Millar pressure catheter
placed in the LV chamber for simultaneous recordings of LVP and LV area. D, representative LV pressure–area
relationships obtained in a urethane-anaesthetized rat under systemic β-adrenoceptor blockade (atenolol). Atrial
pacing at 400 bpm was combined with occlusion of the inferior vena cava to provide a family of pressure–area
loops. To determine end-systolic elastance (Ees), a regression line was drawn between the LVESP–area points of
each loop ensuring r2>0.9.
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to produce a highly selective, rapid and reversible silencing
of neurones expressing AlstR have been described in detail
previously (Mastitskaya et al. 2012).
Young male Sprague-Dawley rats (50–60 g) were
anaesthetized with ketamine (60 mg kg−1 I.M.) and
medetomidine (250 μg kg−1 I.M.). Adequate depth of
surgical anaesthesia was confirmed by the absence of
a withdrawal response to a paw pinch. With the head
fixed prone in a stereotaxic frame, lignocaine (1 ml
of 0.2% solution; Norbrook, Corby, UK) was injected
subcutaneously before a midline dorsal neck incision
was made to expose the atlanto-occipital membrane
and then the dorsal surface of the brainstem. DVMN
was targeted bilaterally with two microinjections per
side (0.25 μl at a rate of 0.05 μl min−1) of a
solution containing LVV-PRSx8-AlstR-IRES-eGFP or
LVV-PRSx8-eGFP (control). To limit potential trans-
fection of the neighbouring A2 neurones, microinjections
of viral vectors were placed 0.1 mm ventral to
the DVMN. This limited/prevented diffusion of viral
particles to the nucleus of the solitary tract while
sparing hypoglossal motoneurones which do not express
Phox2. Taking the calamus scriptorius as the reference
point, the injections were made at 0.5 mm rostral,
0.6 mm lateral, 0.8 mm ventral and at 1.0 mm rostral,
0.8 mm lateral, 0.6 mm ventral. Anaesthesia was reversed
with atipamezole (1 mg kg−1 I.M.). For post-operative
analgesia, rats were administered with buprenorphine
(0.05 mg kg−1 day−1 s.c.) for 3 days. Rats weighed
380–450 g at the time of the experiments.
Glutamate and muscimol microinjections
into the DVMN
The animal was anaesthetized and instrumented as
described above and the head was fixed in the stereotaxic
frame dorsal side up. An occipital craniotomy was
performed and the cerebellum was partially removed
to expose the dorsal surface of the brainstem. A
three-barrelled glassmicropipette (tip size 20–25 μm)was
used for randomized microinjections of either glutamate
or muscimol in three discrete locations along the
rostro-caudal extent of the left and right DVMN. Taking
the calamus scriptorius as the reference point, the micro-
injections were made at 1.3 mm rostral, 0.8 mm lateral,
0.9 mm ventral (rostral area), 0.8 mm rostral, 0.7 mm
lateral, 0.7 mm ventral (intermediate area) and 0.3 mm
rostral, 0.7 mm lateral, 0.7 mm ventral (caudal area).
The barrels of the micropipette contained glutamate or
muscimol, vehicle and saline containing 5% of fluorescent
beads (Invitrogen, Paisley, UK). The injections were made
using pressure over a period of 5–10 s and weremonitored
using a dissecting microscope with a calibrated micro-
meter disc.
Histology
At the end of the experiments the rats were perfused
through the ascending aorta with 0.9% NaCl solution
followed by 500 ml 4% phosphate-buffered (0.1 M,
pH 7.4) paraformaldehyde; the brains were removed
and stored in the same fixative overnight at 4°C. After
cryoprotection in 30% sucrose, the brainstem was iso-
lated and a sequence of transverse slices (30 μm) was
cut. Identification of the transduced DVMN neurones
was enhanced by eGFP immunostaining as described pre-
viously (Marina et al. 2010, 2011; Mastitskaya et al. 2012).
Brainstem sections were first incubated with chicken
anti-GFP antibody (1:1000, Ave´s, Tigard, OR, USA) for
72 h followed by incubation with donkey anti-chicken
Alexa Fluor488 (1:1000, Molecular Probes, Carlsbad,
CA, USA). The anatomical reconstruction of DVMN
distribution of eGFP- and AlstR/eGFP-expressing neuro-
nes was performed manually using the stereotaxic atlas
of Paxinos & Watson (1998) as a guide. Transduced
neurones were counted on both sides of the DVMN
regardless of fluorescence intensity. Brainstem diagrams
were assembled to illustrate the average numbers of
unilaterally transduced neurones per 30 μm slice from
each region of the DVMN.
Experiment 1: to determine the effect of systemic
muscarinic receptor blockade on left ventricular
contractility
The animals were anaesthetized with urethane (maintains
a level of vagal tone) or pentobarbital (reduces vagal
tone), prepared as described above and left to stabilize
for 15–30 min before measurements of baseline cardio-
vascular variables were taken. The effect of systemic
muscarinic receptor blockade (atropine methyl nitrate,
2 mg kg−1 I.V.) on LV contractility was evaluated during
atrial pacing (10% above resting heart rate) in conditions
of systemicβ-adrenoceptor blockade (atenolol) combined
with C1 transection to remove sympathetic influences
(sympathetic blockade). In a separate cohort of animals,
LV pressure recordings and ultrasound LV area imaging
were performed followed by LV pressure–area loop
analysis to determine the effect of atropine methyl nitrate
on LV end-systolic elastance.
Experiment 2: to determine the effect of DVMN
silencing on left ventricular contractility
The animals transduced to express AlstR/eGFP or eGFP
by the DVMNneurones were anaesthetized with urethane
and prepared as described above. To achieve acute
and selective inhibition of DVMN neurones expressing
AlstR, a small occipital craniotomy was performed and
a miniature polyethylene catheter was placed in the
C© 2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
6 A. Machhada and others J Physiol 000.0
cisterna magna to deliver allatostatin (4 μl of 100 μM
solution in artificial cerebrospinal fluid). The animal
was left to stabilize for 15–30 min. The measurements
of cardiovascular variables were taken before and after
allatostatin application in rats expressing AlstR/eGFP
(DVMN silencing) or eGFP (control).
Experiment 3: to identify the region of the DVMN
responsible for the control of left ventricular
contractility
The animals were anaesthetized with pentobarbital
(reduces vagal tone) and prepared as described above.
The dorsal surface of the brainstem was exposed (to aid
microinjections into the DVMN) and the animal was left
to stabilize for 15–30 min. Neurones in discrete locations
along the rostro-caudal extent of the left and right DVMN
were activated following microinjections of an excitatory
amino acid, L-glutamate (10 mM, 40 nl, pH 7.4), and
the effects of these injections on cardiovascular variables
were assessed at resting heart rate conditions, during
atrial pacing (10% above resting heart rate) and under
systemic β-adrenoceptor blockade (atenolol) combined
with C1 transection to remove sympathetic influences. In
a separate cohort of animals anaesthetized with urethane,
caudal DVMNarea (identified to have a significant impact
on LV contractility as a result of studies with the use
of glutamate microinjections) was inhibited by micro-
injection of a potent GABAA receptor agonist, muscimol
(0.1 M, 40 nl, pH 7.4), and the effect of this treatment on
LV contractility was assessed. Microinjections of a vehicle
(0.9% NaCl, 40 nl) were used to determine the effect
of the delivery of a given volume. The order of DVMN
microinjectionswas randomizedbetween the left and right
sites. The sites of DVMN microinjections were identified
histologically and mapped using the stereotaxic atlas of
Paxinos & Watson (1998).
All drugs and reagents used in this study were obtained
from Sigma (Poole, UK) unless otherwise stated.
Data analysis
Recordings of the cardiovascular variables were analysed
using Spike2 software (Cambridge Electronic Design).
LV pressure–area loop analysis was performed using
Lab Chart 8 software (ADInstruments, Oxford, UK).
Differences between the experimental groups were
assessed using GraphPad Prism 6 software (GraphPad
Software Inc., La Jolla, CA, USA). Comparisons were
made using two-way ANOVA (followed by Sidak’s P value
correction for multiple comparisons) or Student’s paired
or unpaired t test, as appropriate. Data are reported as
individual values and means ± SEM. Differences with
P < 0.05 were considered to be significant.
Results
Experiment 1: to determine the effect of systemic
muscarinic receptor blockade on left ventricular
contractility
In rats anaesthetized with urethane and in conditions of
systemic β-adrenoceptor blockade (atenolol) combined
with C1 transection (to remove sympathetic influences),
intravenous administration of atropine methyl nitrate
(2 mg kg−1) led to significant increases in heart
rate, LVdP/dtmax, LVESP and the arterial blood
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Figure 2. Tonic inhibitory muscarinic influence on LV
contractility is preserved under urethane anaesthesia and is
abolished by pentobarbital
A, summary data illustrating average (means ± SEM) values of
LVdP/dtmax obtained in conditions of atrial pacing and systemic
β-adrenoceptor blockade (atenolol) combined with C1 transection
(to remove sympathetic influences) before and after intravenous
administration of atropine methyl nitrate (2 mg kg−1) in rats
anaesthetized with pentobarbital or urethane. B, summary data
illustrating average (means ± SEM) values of end-systolic elastance
(Ees) before and after intravenous administration of atenolol
(2 mg kg−1) in rats anaesthetized with pentobarbital or urethane.
C, summary data illustrating average (means ± SEM) values of Ees in
conditions of β-adrenoceptor blockade (atenolol) before and after
intravenous administration of atropine methyl nitrate (2 mg kg−1) in
rats anaesthetized with pentobarbital or urethane.
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pressure (Supporting Information, Table S1). Increases
in LVdP/dtmax, LVESP and MAP following atropine
administration were also observed during atrial pacing
(Fig. 2A, Supporting Information, Table S1). In rats
anaesthetized with pentobarbital, systemic atropine had
no effect on cardiovascular variables during atrial
pacing in conditions of sympathetic blockade (Fig. 2A,
Supporting Information, Table S1).
In a separate series of experiments, LV pressure–area
loop analysis revealed decreases in LV contractility
following systemic atenolol administration both in
urethane-anaesthetized animals (decrease in Ees from
2.5 ± 0.2 to 1.4 ± 0.2 mmHg mm−2; P = 0.004; Fig. 2B)
and in animals anaesthetized with pentobarbital (decrease
in Ees from2.3± 0.2 to 1.3± 0.2mmHgmm−2;P= 0.001;
Fig. 2B). Subsequent systemic administration of atropine
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Figure 3. Inhibition of vagal preganglionic
neurones in the dorsal motor nucleus of the
vagus nerve (DVMN) increases LV contractility
A, photomicrographs of the coronal sections of the
rat brainstem showing expression of eGFP
(amplified by immunohistochemistry) in a control
animal injected with LVV-PRSx8-eGFP. Images
illustrate representative example of the distribution
of transduced DVMN neurones in the intermediate
and caudal regions of the nucleus. Arrows point at
the efferent DVMN fibres. XII, hypoglossal motor
nucleus; eGFP-IR, eGFP immunoreactivity; CC,
central canal. B, averaged distribution of transduced
DVMN neurones expressing eGFP (left panel) and
AlstR/eGFP (right panel) 5 weeks after
microinjections of LVV-PRSx8-AlstR-IRES-eGFP
(n = 6) or LVV-PRSx8-eGFP (n = 6). Diagrams
illustrate the average numbers of neurones
identified to express the respective transgene in one
30 μm slice taken from the rostral (<13.3 mm
caudal from Bregma), intermediate (13.3–14.0 mm
caudal from Bregma) and caudal (>14.0 mm caudal
from Bregma) regions of the DVMN. Each symbol
represents three transduced cells. In total,
1633 ± 100 eGFP- and 1074 ± 79
AlstR/eGFP-expressing neurones were identified
along the rostro-caudal extent of the left and right
DVMN. No significant specific eGFP labelling was
observed outside the DVMN. 4V, fourth ventricle;
AP, area postrema; NTS, nucleus of the solitary tract.
C, raw traces illustrating the recordings of HR, MAP,
ABP, LVdP/dtmax and LVESP before and after
allatostatin application into the cisterna magna of
rats expressing eGFP or AlstR in the DVMN
(urethane anaesthesia). No significant changes in all
recorded cardiovascular variables were observed
following allatostatin application in rats expressing
eGFP. Inhibition of the DVMN neurones increased
LVdP/dtmax, LVESP and ABP. eGFP, animal transduced
to express eGFP in the DVMN; AlstR, animal
transduced to express AlstR/eGFP in the DVMN. D,
summary data illustrating individual and average
(means ± SEM) values of LVdP/dtmax obtained
before and after allatostatin administration into the
cisterna magna of rats expressing eGFP (n = 6) or
AlstR (n = 6) in the DVMN (urethane anaesthesia,
intact sympathetic tone).
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increased end-systolic elastance in urethane-anaesthetized
(increase in Ees from 1.3± 0.2 to 1.7± 0.2 mmHgmm−2;
P= 0.008; Fig. 2C) but not in pentobarbital-anaesthetized
(1.1 ± 0.1 vs. 1.0 ± 0.1 mmHg mm−2; P = 0.3; Fig. 2C)
animals. These data confirm the existence of a tonic
inhibitorymuscarinic influence on LV contractility, which
in rats is preserved under urethane anaesthesia and is
suppressed by pentobarbital.
Experiment 2: to determine the effect of DVMN
silencing on left ventricular contractility
In rats (urethane anaesthesia), bilateral inhibition of
the DVMN vagal preganglionic neurones transduced to
express AlstR (Fig. 3) was achieved by application of
allatostatin into the cisterna magna. This experiment
was conducted in animals with intact sympathetic tone.
Inhibition of the DVMN neurones increased LVdP/dtmax
(by 922 ± 232 mmHg s−1; P = 0.001; Supporting
Information, Table S2), LVESP (by 16 ± 2 mmHg;
P<0.001; Supporting Information, Table S2) and MAP
(by 7 ± 4 mmHg; P = 0.009; Supporting Information,
Table S2) (Fig. 3C, D). DVMN inhibition had no
effect on heart rate or LVEDP (Supporting Information,
Table S2). No significant changes in all recorded cardio-
vascular variables were observed following allatostatin
application into the cisterna magna in rats expressing
control transgene (eGFP) in the DVMN (Supporting
Information, Table S2) (Fig. 3C, D). These data suggest
that tonic activity of the DVMN vagal pre-ganglionic
neurones has a significant inhibitory effect on LV
contractility.
Experiment 3: to identify the region of the DVMN
responsible for the control of left ventricular
contractility
In rats anaesthetized with pentobarbital, neurones in
discrete locations along the rostro-caudal extent of
the left and right DVMN (Fig. 4) were activated
by glutamate microinjections and the effects of these
treatments on cardiovascular variables were first assessed
at resting heart rate conditions (Supporting Information,
Table S3). Activation of neurones in the left caudal area
of the DVMN (Fig. 4) induced decreases in LVdP/dtmax
(by 1641 ± 134 mmHg s−1; P < 0.001), LVESP (by
28 ± 3 mmHg; P < 0.001), MAP (by 26 ± 3 mmHg;
P < 0.001) and heart rate (by 20 ± 6 bpm; P = 0.01)
(Supporting Information, Table S3; Fig. 5). Activation of
the intermediate DVMN area located 0.5 mm rostrally
(Fig. 4) decreased LVdP/dtmax (by 420 ± 112 mmHg s−1;
P = 0.01; Supporting Information, Table S3) and MAP
(by 10 ± 3 mmHg; P = 0.001; Supporting Information,
Table S3), although the magnitude of the evoked changes
was smaller compared to the responses elicited by
glutamate actions at the caudal site. Activation of the
most rostral area of the left DVMN or any area along the
rostro-caudal extent of the right DVMN had no effect
on cardiovascular variables (Supporting Information,
Table S3). Sites of microinjections were marked by
fluorescent beads and were confirmed to lie within the
targeted DVMN regions (Fig. 4B).
Under constant heart rate conditions (pacing at 10%
above resting heart rate) activation of neurones in the left
caudal DVMN area was also associated with significant
decreases in LVdP/dtmax (by 1536 ± 164 mmHg s−1;
P < 0.001), LVESP (by 19 ± 4 mmHg; P < 0.001)
and MAP (by 23 ± 3 mmHg; P < 0.001) with no
effect on LVEDP (Supporting Information, Table S4,
Fig. 5). Smaller, yet significant decreases in LVdP/dtmax
(by 475 ± 140 mmHg s−1; P = 0.004), LVESP (by
9 ± 4 mmHg; P = 0.04) and MAP (by 8 ± 3 mmHg;
P = 0.02) were evoked by stimulation of neurones in the
left caudal DVMN under constant heart rate conditions
combined with systemic β-adrenoceptor blockade and C1
rostral
A
B
rostral
DVMN
DVMN
DVMN 1 mm
XII
XII
NTS
intermediate
caudal
caudal
AP
NTS
2 mm
4V
4V
Figure 4. Microinjection sites along the rostro-caudal extent
of the left and right DVMN
A, schematic drawing of the rat brainstem viewed from its dorsal
surface illustrating targeting of the rostral, intermediate and caudal
aspects of the left and right DVMN. B, schematic drawings of the
coronal sections of the rat brainstem illustrating the locations of the
rostral, intermediate and caudal microinjection sites identified by
deposition of fluorescent beads. AP, area postrema; NTS, nucleus of
the solitary tract; S, solitary tract.
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transection (Supporting Information, Table S4, Fig. 5).
Responses triggered by glutamate-induced activation of
the left caudal DVMN were abolished by atropine
(Supporting Information, Table S4).
In animals anaesthetizedwith urethane (under systemic
β-adrenoceptor blockade combined with C1 trans-
ection), inhibition of the left caudal DVMN following
microinjections of muscimol increased LVdP/dtmax (by
873 ± 151 mmHg s−1; P < 0.001), LVESP (by
17 ± 4 mmHg; P = 0.001), MAP (by 10 ± 1 mmHg;
P = 0.001) and heart rate (by 13 ± 5 bpm; P = 0.004)
(Supporting Information, Table S5, Fig. 6). As silencing
of the DVMN neurones transduced to express AlstR by
allatostatin was not associated with changes in heart
rate, the cardiovascular response profile recorded after
muscimol microinjections suggested potential diffusion
and actions of the drug on neurones of the neighbouring
brainstem structures (e.g. nucleus of the solitary tract).
Smaller yet significant increases in LVdP/dtmax and LVESP
in response to inhibition of the left caudal DVMN were
observed during atrial pacing (Supporting Information,
Table S5, Fig. 6). Inhibition of the right caudal DVMN
by muscimol produced no changes in cardiovascular
variables (Supporting Information, Table S5, Fig. 6).
Discussion
In the present study we tested the hypothesis that tonic
parasympathetic control of left ventricular contractility is
provided by vagal preganglionic neurones that reside in
the DVMN. First, using an anaesthetized rat model, we
confirmed the presence of tonic restraining muscarinic
influence on LV inotropy. Next, DVMN neurones were
targeted to express inhibitory G-protein-coupled receptor
from insects, and their selective silencing following
application of the insect peptide allatostatin (Mastitskaya
et al. 2012) was found to be associated with significant
increases in LV contractility. Although vagal preganglionic
neurones residing in the nucleus ambiguus are likely to
have an impact on LV function, the data obtained in the
present study support the hypothesis that a significant
component of the parasympathetic control of LV inotropy
is indeed provided by tonically active neurones of the
DVMN. Functional neuroanatomical mapping, using
glutamate and muscimol microinjections to activate and
inhibit neuronal cell bodies in distinct locations along the
rostro-caudal extent of the left and rightDVMN, identified
the anatomical location of vagal preganglionic neurones
that have an impact on LV contractility. These neurones
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Figure 5. Activation of neurones in the caudal region of the left DVMN decreases LV contractility
A, raw traces illustrating recordings of HR, MAP, ABP, LVdP/dtmax and LVESP before and after glutamate micro-
injections into the caudal region of the left DVMN at resting heart rate conditions, during atrial pacing and after
systemic β-adrenoceptor blockade (atenolol) combined with spinal cord (C1) transection to remove sympathetic
influences (pentobarbital anaesthesia). L-glu, L-glutamate; SB, sympathetic blockade. B, summary data illustrating
individual and average (means ± SEM) values of peak changes in LVESP and LVdP/dtmax induced by glutamate
microinjections into the caudal regions of DVMN at resting heart rate conditions, during atrial pacing and during
atrial pacing combined with sympathetic blockade. No significant changes in all recorded cardiovascular variables
were observed following activation of the right DVMN, so the effects of glutamate microinjections were only
assessed at resting conditions.
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appear to be concentrated in the caudal region of the left
DVMN.
The strength and significance of tonic parasympathetic
modulationofLV inotropic statehave remainedunknown.
Earlier studies conducted in dogs, pigs and humans
demonstrated that electrical stimulation of the vagus
nerve leads to load-independent decreases in LV contra-
ctility (Degeest et al. 1964, 1965c; Lewis et al. 2001).
The evidence of changes in LV inotropy observed
in a reverse experimental paradigm, i.e. when acute
bilateral vagotomy is performed or systemic muscarinic
receptor blockade is applied, is limited. Degeest et al.
(1965a,b) reported that bilateral vagotomy blocks the
negative inotropic effect of peripheral chemoreceptor
stimulation. In humans, intracoronary administration of
ACh attenuated inotropic responses to β-adrenoceptor
stimulation (dobutamine infusion) (Landzberg et al.
1994). Interestingly, intracoronary atropine potentiated
dobutamine-induced inotropic responses, and this effect
of atropine was absent in transplanted (i.e. denervated)
hearts (Landzberg et al. 1994). These data demonstrated
the existence of a tonic restraining parasympathetic
influence on LV contractility in humans. A more
recent study reported increases in LVESP after acute
bilateral vagotomy in the arterially perfused working
heart–brainstem rat preparation (Nalivaiko et al. 2010).
Here, using two different measures we confirmed
the existence of tonic inhibitory muscarinic influence
on LV contractility in a rat model. Under systemic
β-adrenoceptor blockade, intravenous administration
of atropine increased LV end-systolic elastance and
LVdP/dtmax (at constant filling times and loading
conditions). Systemic muscarinic receptor blockade
increased LV contractility only in animals anaesthetized
with urethane, confirming previous reports that urethane
preserves, andpentobarbital reduces (chronotropic), vagal
tone (O’Leary & Jones, 2003). These data illustrate a tonic
inhibitory muscarinic influence on LV contractility and
sensitivity of this influence to anaesthetic agents, which
suppress parasympathetic tone.
In an earlier studywe found that the increased activity of
DVMN vagal preganglionic neurones protects LV cardio-
myocytes against acute ischaemia/reperfusion injury. This
cardioprotective effect was found to be mediated by a
muscarinic mechanism (Mastitskaya et al. 2012). Based
on these data, we hypothesized that the same population
of DVMN neurones that exerts powerful cardioprotection
may also contribute to the control of ventricular contra-
ctility. Acute bilateral inhibition of AlstR-expressing
DVMN neurones along the rostro-caudal extent of the
nuclei (by allatostatin infusion) increased LVdP/dtmax,
LVESP and ABP. This effect suggested an increase in LV
contractility as no changes in LVEDP or heart rate were
observed. Functional neuroanatomical mapping (using
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Figure 6. Inhibition of neurones in the caudal region of the left DVMN increases LV contractility
A, raw traces illustrating recordings of HR, MAP, ABP, LVdP/dtmax and LVESP before and after muscimol micro-
injections into the caudal region of the left DVMN under systemic β-adrenoceptor blockade (atenolol) combined
with spinal cord (C1) transection at resting heart rate and during atrial pacing (urethane anaesthesia). B, summary
data illustrating individual and average (means ± SEM) values of peak changes in LVESP and LVdP/dtmax resulting
from muscimol microinjections into the caudal regions of DVMN in conditions of sympathetic blockade at resting
heart rate and during atrial pacing. No significant changes in all recorded cardiovascular variables were observed
following muscimol microinjections into the right caudal DVMN.
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microinjections of glutamate and muscimol to activate
and inhibit DVMN neuronal cell bodies, respectively)
revealed that vagal preganglionic neurones responsible
for parasympathetic control of LV inotropic state are
concentrated in the caudal region of the left DVMN.
At resting heart rate conditions (prior to
β-adrenoceptor blockade and spinal cord trans-
ection) microinjections of glutamate into the left caudal
DVMN induced marked changes in heart rate and ABP,
indicative of a sympathetic withdrawal. These effects
could be explained by glutamate diffusion from the site
of microinjection and its actions on neurones of the
neighbouring nucleus of the solitary tract, which receives
inputs from all cardiorespiratory afferents (Spyer, 1994)
and/or acute recruitment of the inhibitory presynaptic
vagal influences which control noradrenaline release
from sympathetic terminals innervating the heart. The
magnitude of the parasympathetic effects on heart rate is
well known to depend on the strength of the sympathetic
tone, indicative of the effective functional presynaptic
interactions (Levy, 1971).
Activation of neurones in the caudal region of the left
DVMN led to a significant decrease in LV contractility also
in conditions of systemic β-adrenoceptor blockade and
spinal cord transection, suggesting that parasympathetic
control of LV inotropy originates from this region of the
brainstem. Microinjections of glutamate trigger transient
activation of the neuronal cell bodies in the targeted brain
area and have no effect on the fibres of passage (Goodchild
et al. 1982). This was important for the design of the
current study as axons of vagal preganglionic neurones of
the nucleus ambiguus form hairpin loops in the vicinity
of the DVMN (Jones, 2001).
The short duration and unimodal cardiovascular
response profile after microinjections of glutamate
suggested that activation of neurones in the neighbouring
brainstem structures is unlikely. To minimize the
likelihood of this, we used one-fifth of the glutamate
concentration originally described (Goodchild et al. 1982)
and one-tenth of the glutamate concentration used to
recruit vagal preganglionic neurones of the nucleus
ambiguus (Sampaio et al. 2003). Interestingly, relative
decreases in LV contractility triggered in response to
activation of the neuronal cell bodies in the left caudal
DVMN were quantitatively similar (20%) to those
observed in rabbits when vagus nerve stimulation was
combined with the anodal block technique for selective
stimulation of unmyelinated efferent fibres (Garcia Perez
& Jordan, 2001). These data support the conclusions of
the present study, as only DVMN vagal preganglionic
neurones have C fibre axons (neurones of the nucleus
ambiguus have B fibre axons). Inhibition of neurones
in the left caudal area of the DVMN using micro-
injections of a potent GABAA receptor agonist, muscimol,
increased LV contractility, although the magnitude of
the observed effects was smaller than that induced by
systemicmuscarinic receptor blockade. These data suggest
that either muscimol microinjections were not sufficient
to inhibit the same population of DVMN neurones
recruited by the actions of glutamate, or vagal pre-
ganglionic neurones residing in the nucleus ambiguus also
contribute to the parasympathetic control of LV inotropy,
or both.
There is evidence that cardiomyocytes themselves are
able to synthesize ACh and ACh synthesis by cardio-
myocytes is facilitated by muscarinic receptor activation
(Kakinuma et al. 2009, 2012; Sun et al. 2013). Despite
an ongoing debate on the density of vagal innervation of
the LV myocardium, there is strong evidence that vagus
nerve stimulation is associated with significant increases
in LV ACh content (Eliakim et al. 1961; Akiyama et al.
1994; Akiyama & Yamazaki, 2001). If cardiomyocytes are
capable of producing physiologically significant amounts
of ACh in an autocrine/paracrine manner (sensitive to
muscarinic receptor agonism), activation of an even sparse
vagal efferent innervation may have a significant impact
on LV function. LV cardiomyocytes are protected against
ischaemia/reperfusion injury when the activity of DVMN
neurones is selectively recruited using an optogenetic
approach (Mastitskaya et al. 2012) – the data are consistent
with the evidenceof apotent cardioprotective effect ofACh
(which is as potent as adenosine in reducing myocardial
injury) reported previously (Richard et al. 1995;Qian et al.
1996; Yamaguchi et al. 1997; Cohen et al. 2001).
In summary, the data obtained in the present study
confirm the existence of a tonic inhibitory muscarinic
influence on LV contractility, which in the rat is preserved
under urethane anaesthesia and is abolished by pento-
barbital. Functionally significant parasympathetic control
of LV contractile function originates from the activity of
a group of vagal pre-ganglionic neurones residing in the
caudal region of the left DVMN.
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